The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nuclear factor-κB in cancer development and progression
Abstract
Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When NF-κB is activated, transcription of proinflammatory immune response genes such as Tnfα and Il1 occurs, which leads to translation and production of proinflammatory cytokines that serve to coordinate the inflammatory response (Karin, 2006).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Karin, 2006
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,010
Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein
Bernier, M., Paul, R. K., Martín‐Montalvo, A., Scheibye‐Knudsen, M., Song, S., He, H., Armour, S. M., Hubbard, B. P., Bohr, V. A., Wang, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200311 · Cited by 133
Pancreatic cancer: Pathogenesis, prevention and treatment
Sarkar, F. H., BANERJEE, S., & LI, Y. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.11.007 · Cited by 127
Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine
Dong, T., Li, C., Wang, X., Dian, L., Zhang, X., Li, L., Chen, S., Cao, R., Li, L., Huang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7522 · Cited by 126
Kimura, Y., Kono, S., Toyomura, K., Nagano, J., Mizoue, T., Moore, M. A., Mibu, R., Tanaka, M., Kakeji, Y., Maehara, Y., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00425.x · Cited by 126
PTP1B and TC-PTP: regulators of transformation and tumorigenesis
Stuible, M., Doody, K. M., & Tremblay, M. L. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9115-1 · Cited by 130
Soutto, M., Belkhiri, A., Piazuelo, M. B., Schneider, B., Peng, D., Jiang, A., Washington, M. K., Kokoye, Y., Crowe, S. E., Zaika, A. I., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43922 · Cited by 125
Kimura, Y. N., Watari, K., Fotovati, A., Hosoi, F., Yasumoto, K., Izumi, H., Kohno, K., Umezawa, K., Iguchi, H., Shirouzu, K., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00633.x · Cited by 129
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
Kumar, V. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9349-9 · Cited by 131
MAP Kinases and Prostate Cancer
Rodríguez‐Berriguete, G., Fraile, B., Martínez-Onsurbe, P., Olmedilla, G., Paniagua, R., & Royuela, M. (2011) · Journal of Signal Transduction · doi:10.1155/2012/169170 · Cited by 127
NF-κB: a new player in angiostatic therapy
Tabruyn, S. P., & Griffioen, A. W. (2008) · Angiogenesis · doi:10.1007/s10456-008-9094-4 · Cited by 124
Rethinking the metastatic cascade as a therapeutic target
Mina, L. A., & Sledge, G. W. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.59 · Cited by 123
Transcription Factor NF-κB: An Update on Intervention Strategies
Panday, A., Inda, M. E., Bagam, P., Sahoo, M. K., Osorio, D., & Batra, S. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0405-y · Cited by 124
The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
Vrábel, D., Pour, L., & Ševčíková, S. (2019) · Blood Reviews · doi:10.1016/j.blre.2018.11.003 · Cited by 123
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Kleczko, E. K., Kwak, J., Schenk, E. L., & Nemenoff, R. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00954 · Cited by 122
CCR7 as a therapeutic target in Cancer
Salem, A., Alamir, M. B., Mroueh, R., Basheer, H. A., & Afarinkia, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188499 · Cited by 128
Garlanda, C., Riva, F., Veliz, T., Polentarutti, N., Pasqualini, F., Radaelli, E., Sironi, M., Nebuloni, M., Zorini, E. O., Scanziani, E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0560 · Cited by 125
Benjamin, J. M., & Nelson, W. J. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.08.003 · Cited by 127
Yao, J., Zhao, L., Zhao, Q., Zhao, Y., Sun, Y., Zhang, Y., Miao, H., You, Q.-D., Hu, R., & Guo, Q.-L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.221 · Cited by 123
Ivanov, V. N., Zhou, H., Ghandhi, S. A., Karasic, T. B., Yaghoubian, B., Amundson, S. A., & Hei, T. K. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.02.010 · Cited by 128
Yang, X., Lü, H., Yan, B., Romano, R.-A., Bian, Y., Friedman, J., Duggal, P., Allen, C. T., Chuang, R. J., Ehsanian, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3445 · Cited by 122
Du, Q., Zhang, X., Cardinal, J. S., Cao, Z., Guo, Z., Shao, L., & Geller, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0014 · Cited by 124
The NF-κB member p65 controls glutamine metabolism through miR-23a
Rathore, M. G., Saumet, A., Rossi, J.-F., de Bettignies, C., Tempé, D., Lecellier, C.-H., & Villalba, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.011 · Cited by 129
Schumacher, M. M., Cerella, C., Reuter, S., Dicato, M. A., & Diederich, M. F. (2010) · Genes & Nutrition · doi:10.1007/s12263-010-0194-6 · Cited by 124
Targeting tumor associated macrophages (TAMs) via nanocarriers
Singh, Y., Pawar, V. K., Meher, J. G., Raval, K., Kumar, A., Shrivastava, R., Bhadauria, S., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.395 · Cited by 122
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul, H. S. (2007) · Frontiers in bioscience · doi:10.2741/2900 · Cited by 121
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3596 · Cited by 121
Histone methylation modifiers in cellular signaling pathways
Alam, H., Gu, B., & Lee, M. G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2023-y · Cited by 124
Mechanisms of Immune Signaling in Colitis-Associated Cancer
Waldner, M. J., & Neurath, M. F. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 119
Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells
Kendellen, M. F., Bradford, J. W., Lawrence, C. L., Clark, K. S., & Baldwin, A. S. (2013) · Oncogene · doi:10.1038/onc.2013.64 · Cited by 120
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
Sudhakar, C., Nagabhushana, A., Jain, N. S., & Swarup, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005114 · Cited by 119
Mechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
Katsha, A. M., Soutto, M., Sehdev, V., Peng, D., Washington, M. K., Piazuelo, M. B., Tantawy, M. N., Manning, H. C., Lu, P., Shyr, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.050 · Cited by 116
Targeting of proangiogenic signalling pathways in chronic inflammation
Tas, S. W., Maracle, C. X., Balogh, E., & Szekanecz, Z. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.164 · Cited by 123
Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players
Othman, N., Jamal, R., & Abu, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02103 · Cited by 121
Selenium-enriched plant foods: Selenium accumulation, speciation, and health functionality
Tangjaidee, P., Swedlund, P. J., Xiang, J., Yin, H., & Quek, S. Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.962312 · Cited by 124
Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Miyashita, K., Kawakami, K., Nakada, M., Mai, W., Shakoori, A., Fujisawa, H., Hayashi, Y., Hamada, J., & Minamoto, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0760 · Cited by 120
Inflammation and cancer: Till death tears them apart
Raposo, T. P., Beirão, B. C. B., Pang, L. Y., QUEIROGA, F. L., & Argyle, D. J. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.04.015 · Cited by 121
Zhao, Z., Wu, M.-S., Zou, C., Tang, Q., Lu, J., Liu, D., Wu, Y., Yin, J., Xie, X., Shen, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.042 · Cited by 118
The Function of the Mutant p53-R175H in Cancer
Chiang, Y.-T., Chien, Y., Lin, Y., Wu, H.-H., Lee, D., & Yu, Y. (2021) · Cancers · doi:10.3390/cancers13164088 · Cited by 127
Use of Tumor Necrosis Factor-α Inhibitors in Patients with Chronic Hepatitis B Infection
Carroll, M. B., & Bond, M. I. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.10.011 · Cited by 118
Role of tumour-associated macrophages in cancer-related inflammation.
Sica, A. (2010) · PubMed · Cited by 117
Wang, Z. P., Kong, D., Banerjee, S., Li, Y., Adsay, V. N., Abbruzzese, J. L., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2803 · Cited by 117
RetractedNF-κB Gene Signature Predicts Prostate Cancer Progression
Jin, R., Yi, Y., Yull, F. E., Blackwell, T. S., Clark, P. E., Koyama, T., Smith, J. A. J., & Matusik, R. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2543 · Cited by 118
Current Understanding of Flavonoids in Cancer Therapy and Prevention
Farhan, M., Rizvi, A., Aatif, M., & Ahmad, A. (2023) · Metabolites · doi:10.3390/metabo13040481 · Cited by 128
Kiessling, M. K., Klemke, C. D., Kamiński, M. M., Galani, I. E., Krammer, P. H., & Gülow, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3221 · Cited by 115
Alberti, C., Pinciroli, P., Valeri, B., Ferri, R., Ditto, A., Umezawa, K., Sensi, M., Canevari, S., & Tomassetti, A. (2011) · Oncogene · doi:10.1038/onc.2011.572 · Cited by 115
Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies
Mostofa, A., Hossain, M. K., Basak, D., & Sayeed, M. S. B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00295 · Cited by 121
Chemopreventive activity of sulforaphane
Jiang, X. M., Liu, Y., Ma, L., Ji, R., Qu, Y., Xin, Y., & Lv, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s100534 · Cited by 115
Qiu, X., Du, Y., Lou, B., Zuo, Y., Shao, W., Huo, Y., Huang, J., Yu, Y., Zhou, B., Du, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004545 · Cited by 115
Natural isothiocyanates: Genotoxic potential versus chemoprevention
Fimognari, C., Turrini, E., Ferruzzi, L., Lenzi, M., & Hrelia, P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.001 · Cited by 116
Mechanism Underlying IκB Kinase Activation Mediated by the Linear Ubiquitin Chain Assembly Complex
Fujita, H., Rahighi, S., Akita, M., Kato, R., Sasaki, Y., Wakatsuki, S., & Iwaï, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01538-13 · Cited by 117
Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway
Hu, L., Zang, M., Wang, H., Li, J., Su, L., Yan, M., Li, C., Yang, Q., Liu, B., & Zhu, Z. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.08.002 · Cited by 112
Liu, F., Dai, M., Xu, Q., Zhu, X., Zhou, Y., Jiang, S., Wang, Y., Ai, Z., Ma, L., Zhang, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0119-6 · Cited by 113
Manipulating the chemokine‐chemokine receptor network to treat cancer
Ruffini, P. A., Morandi, P., Cabıoğlu, N., Altundağ, K., & Cristofanilli, M. (2007) · Cancer · doi:10.1002/cncr.22706 · Cited by 114
Activated macrophages induce metastatic behavior of colon cancer cells
Jedinak, A., Dudhgaonkar, S. P., & Slíva, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.03.004 · Cited by 114
Markovina, S. S., Callander, N. S., O’Connor, S. L., Xu, G., Shi, Y., Leith, C. P., Kim, K., Trivedi, P., Kim, J., Hematti, P., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-176 · Cited by 113
Baicalein inhibits the migration and invasive properties of human hepatoma cells
Chiu, Y.-W., Lin, T.-H., Huang, W.-S., Teng, C.-Y., Liou, Y., Kuo, W., Lin, W.-L., Huang, H.-I., Tung, J.-N., Huang, C., et al. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.008 · Cited by 113
Cytokine regulation networks in the cancer microenvironment
Sheu, B. (2008) · Frontiers in bioscience · doi:10.2741/3152 · Cited by 116
Chronic inflammation and pancreatic cancer
McKay, C. J., Glen, P., & McMillan, D. C. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.11.007 · Cited by 113
Lovett, D. H., Mahimkar, R., Raffaı̈, R. L., Cape, L., Maklashina, E., Cecchini, G., & Karliner, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034177 · Cited by 112
Wang, S., Wu, X., Zhang, J., Chen, Y., Xu, J., Xia, X., He, S., Qiang, F., Li, A., Shu, Y., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301522 · Cited by 111
p62/ SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 117
Self-citationComponents of the hepatocellular carcinoma microenvironment and their role in tumor progression
Новикова, М. В., Хромова, Н. В., & Kopnin, P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917080016 · Cited by 113
Regulation of apoptosis by the circadian clock through NF-κB signaling
Lee, J. H., & Sancar, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108125108 · Cited by 117
NF-κB and the intestine: Friend or foe?
Karrasch, T., & Jobin, C. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20243 · Cited by 111
Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
Marín‐Aguilera, M., Codony‐Servat, J., Kalko, S. G., Fernández, P. L., Bermudo, R., Buxó, E., Ribal, M. J., Gascón, P., & Mellado, B. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0289 · Cited by 111
Genetic relationships betweenA20/TNFAIP3, chronic inflammation and autoimmune disease
Vereecke, L., Beyaert, R., & Loo, G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391086 · Cited by 110
Xie, C. L., Liu, D., Chen, Q., Yang, C., Wang, B., & Wu, H. (2016) · Scientific Reports · doi:10.1038/srep27528 · Cited by 111
Targeting Toll-Like Receptors for Cancer Therapy
Braunstein, M. J., Kucharczyk, J. R., & Adams, S. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0589-7 · Cited by 114
Bcl10 and Malt1 control lysophosphatidic acid-induced NF-κB activation and cytokine production
Klemm, S., Zimmermann, S., Peschel, C., Mak, T. W., & Ruland, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608388103 · Cited by 111
Lien, S.-C., Chang, S., Lee, P.-L., Wei, S., Chang, M. D., Chang, J., & Chiu, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.023 · Cited by 111
Klammer, H., Mladenov, E., Li, F., & Iliakis, G. E. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.017 · Cited by 120
Zhao, B., Ma, Y., Xu, Z., Wang, J., Wang, F., Wang, D., Pan, S., Wu, Y., Pan, H., Xu, D., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.028 · Cited by 110
Far, B. F., Vakili, K. G., Fathi, M., Yaghoobpoor, S., Bhia, M., & Naimi‐Jamal, M. R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121340 · Cited by 114
Housseau, F., & Sears, C. L. (2010) · Cell Cycle · doi:10.4161/cc.9.1.10352 · Cited by 110
Afzal, M. R., Haider, H. K., Idris, N. M., Jiang, S., Ahmed, R. P. H., & Ashraf, M. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2755 · Cited by 109
Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation
An, J., Mo, D., Liu, H., Veena, M. S., Srivatsan, E. S., Massoumi, R., & Rettig, M. B. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.007 · Cited by 115
Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics
Berghe, W. V., Ndlovu, ’. N., Hoya-Arias, R., Dijsselbloem, N., Gerlo, S., & Haegeman, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.012 · Cited by 108
Noncanonical TGF-β Signaling During Mammary Tumorigenesis
Parvani, J. G., Taylor, M. A., & Schiemann, W. P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9207-3 · Cited by 112
Yore, M. M., Liby, K. T., Honda, T., Gribble, G. W., & Sporn, M. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0444 · Cited by 109
Yin, M., Ren, X., Zhang, X., Luo, Y., Wang, G., Huang, K., Feng, S., Bao, X., Huang, K., He, X., et al. (2014) · Oncogene · doi:10.1038/onc.2013.597 · Cited by 110
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
Yesudhas, D., Gosu, V., Anwar, M. A., & Choi, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00334 · Cited by 112
Yang, Z., Xian, H., Hu, J., Tian, S., Qin, Y., Wang, R., & Cui, J. (2015) · Scientific Reports · doi:10.1038/srep12738 · Cited by 108
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Zhang, L., Xu, X., & Su, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01154-0 · Cited by 104
The effect of insomnia on development of Alzheimer’s disease
Sadeghmousavi, S., Eskian, M., Rahmani, F., & Rezaei, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01960-9 · Cited by 122
Chen, M., Xiao, C., Jiang, W., Yang, W., Qin, Q., Tan, Q., Lian, B., Liang, Z.-J., & Wei, C. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s269901 · Cited by 113
Formentini, L., Pereira, M. P., Sánchez-Cenizo, L., Santacatterina, F., Lucas, J. J., Fernández-Balbuena, C. N., Martı́nez-Serrano, A., & Cuezva, J. M. (2014) · The EMBO Journal · doi:10.1002/embj.201386392 · Cited by 111
Estrogen, NFκB, and the Heat Shock Response
Stice, J. P., & Knowlton, A. A. (2008) · Molecular Medicine · doi:10.2119/2008-00026.stice · Cited by 109
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Varghese, E., Samuel, S. M., Abotaleb, M., Cheema, S., Mamtani, R., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers10100346 · Cited by 114
Honey Polyphenols Ameliorate DSS‐Induced Ulcerative Colitis via Modulating Gut Microbiota in Rats
Zhao, H., Cheng, N., Zhou, W., Chen, S., Wang, Q., Gao, H. Y., Xue, X., Wu, L., & Cao, W. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900638 · Cited by 109
Vandermark, E., Deluca, K. A., Gardner, C. R., Marker, D. F., Schreiner, C. N., Strickland, D. A., Wilton, K. M., Mondal, S., & Woodworth, C. D. (2012) · Virology · doi:10.1016/j.virol.2011.12.023 · Cited by 108
Prakobwong, S., Khoontawad, J., Yongvanit, P., Pairojkul, C., Hiraku, Y., Sithithaworn, P., Pinlaor, P., Aggarwal, B. B., & Pinlaor, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25656 · Cited by 106
Shih, V. F.-S., Kearns, J. D., Basak, S., Savinova, O. V., Ghosh, G., & Hoffmann, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812367106 · Cited by 106
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma
Chung, H. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1667 · Cited by 106
O’Leary, D., Bhatt, L., Woolley, J. F., Gough, D. R., Wang, J. H., Cotter, T. G., & Redmond, H. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044176 · Cited by 106
Jing, N., Du, Y., Chen, X., Bai, Q., Wang, Y., Zhang, X., Zhu, N., Zhang, J., Hou, J., Wang, Q. L., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0464 · Cited by 109
Неганова, М. Е., Liu, J., Aleksandrova, Y. R., Klochkov, S. G., & Fan, R. (2021) · Cancers · doi:10.3390/cancers13236062 · Cited by 112
The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer
García-Hernández, L., García‐Ortega, M. B., Ruiz-Alcalá, G., Carrillo, E., Marchal, J. A., & García, M. Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010370 · Cited by 111
The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure
Fu, Y., Yu, X., Wang, Y., Liu, Z., Yang, D., Zha, J., Tang, C., Cai, J., Chen, G., & Dong, Z. (2023) · Theranostics · doi:10.7150/thno.81406 · Cited by 112
Metadata
- Authors
- Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- ORCID
- Karin, Michael
- Venue
- Nature
- Published
- 2006-05
- Volume
- 441
- Issue
- 7092
- Pages
- 431-436
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2315613727
- Cited by
- 3,519
- References
- 71
- Citations by year
- 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
- MeSH terms
- Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review